StonvexLoading…
StonvexStonvexStonvexCore line items from ANGX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $115.11M | $321.56M | $211.62M | $47.44M |
Operating Income | $-2.67M | $-164.11M | $-93.23M | $-33.59M |
Net Income | $-13.80M | $-170.48M | $-91.85M | $-37.30M |
EPS (Diluted) | $-0.08 | $-1.10 | $-0.61 | $-0.26 |
Total Assets | $213.09M | $241.41M | $197.00M | $1.03M |
Total Liabilities | $254.55M | $267.19M | $159.83M | $9.20M |
Cash & Equivalents | $38.88M | $44.08M | $63.33M | $14.19M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 169.85M | 169.10M | 168.63M | 145.62M |